Page last updated: 2024-10-19

oxamic acid and Prostatic Neoplasms, Castration-Resistant

oxamic acid has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies

Oxamic Acid: Amino-substituted glyoxylic acid derivative.
oxamic acid : A dicarboxylic acid monoamide resulting from the formal condensation of one of the carboxy groups of oxalic acid with ammonia.

Prostatic Neoplasms, Castration-Resistant: Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Muramatsu, H1
Sumitomo, M1
Morinaga, S1
Kajikawa, K1
Kobayashi, I1
Nishikawa, G1
Kato, Y1
Watanabe, M1
Zennami, K1
Kanao, K1
Nakamura, K1
Suzuki, S1
Yoshikawa, K1

Other Studies

1 other study available for oxamic acid and Prostatic Neoplasms, Castration-Resistant

ArticleYear
Targeting lactate dehydrogenase‑A promotes docetaxel‑induced cytotoxicity predominantly in castration‑resistant prostate cancer cells.
    Oncology reports, 2019, Volume: 42, Issue:1

    Topics: Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Docetaxel; Down-Regulation; Drug Re

2019